PubRank

Adam L Boxer

Author PubWeight™ 55.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011 20.15
2 Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging 2011 3.27
3 Criteria for the diagnosis of corticobasal degeneration. Neurology 2013 3.07
4 Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol 2013 2.26
5 Clinicopathological correlations in corticobasal degeneration. Ann Neurol 2011 1.86
6 TDP-43 frontotemporal lobar degeneration and autoimmune disease. J Neurol Neurosurg Psychiatry 2013 1.74
7 Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology 2012 1.69
8 Dissociable executive functions in behavioral variant frontotemporal and Alzheimer dementias. Neurology 2013 1.65
9 Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc Natl Acad Sci U S A 2009 1.49
10 Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet 2012 1.46
11 Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease. Brain 2008 1.36
12 Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J Neurol Neurosurg Psychiatry 2012 1.34
13 Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells. Stem Cell Reports 2013 1.16
14 Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Ann Neurol 2014 1.15
15 Bapineuzumab. Expert Opin Biol Ther 2010 1.12
16 Off-label medication use in frontotemporal dementia. Am J Alzheimers Dis Other Demen 2010 1.01
17 Anti-saccade performance predicts executive function and brain structure in normal elders. Cogn Behav Neurol 2011 0.98
18 Deformation-based morphometry reveals brain atrophy in frontotemporal dementia. Arch Neurol 2007 0.97
19 Mutual gaze in Alzheimer's disease, frontotemporal and semantic dementia couples. Soc Cogn Affect Neurosci 2010 0.94
20 Gray matter correlates of set-shifting among neurodegenerative disease, mild cognitive impairment, and healthy older adults. J Int Neuropsychol Soc 2010 0.94
21 Practical utility of amyloid and FDG-PET in an academic dementia center. Neurology 2013 0.93
22 Patterns of striatal degeneration in frontotemporal dementia. Alzheimer Dis Assoc Disord 2013 0.92
23 Intrinsic connectivity network disruption in progressive supranuclear palsy. Ann Neurol 2013 0.91
24 Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease. Alzheimer Dis Assoc Disord 2013 0.90
25 Baseline predictors of clinical progression among patients with dysexecutive mild cognitive impairment. Dement Geriatr Cogn Disord 2010 0.86
26 Clinical and neuropsychological features of corticobasal degeneration. Mech Ageing Dev 2005 0.86
27 Visual search patterns in semantic dementia show paradoxical facilitation of binding processes. Neuropsychologia 2011 0.85
28 Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease. J Mol Neurosci 2011 0.83
29 Antisaccade task reflects cortical involvement in mild cognitive impairment. Neurology 2013 0.82
30 Treatment of frontotemporal dementia. Curr Treat Options Neurol 2014 0.79